ARCHIVES

NCI “Can’t Justify Size Of Intramural Program”

This article is from The Cancer Letter archive.

Vol. 21 No. 19 | May 12, 1995

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

NIH Programs: Advisory Panel Formed On Cancer and Alternative Medicine

July 16, 1999

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

Fibrolast Interferon Contract Signed

May 2, 1980